Paying participants for the essential role that they play in clinical trials is important, but the amount given, and how it is paid, requires careful consideration.
Compensation increases recruitment, allowing studies to be completed efficiently, saving time, money, and staff resources. It also recognizes participants for their contribution to advancing medical science. But how can sponsors, CROs and sites strike the right balance between compensating research participants to achieve those benefits, while minimizing the potential for the payments to have an undue influence on their behavior?
Join this one-hour webinar with our industry experts as they:
- Interpret the regulatory guidances from FDA, OHRP and SACHRP on compensation
- Shed light on the different types of compensation and payments clinical trial participants can receive in a study
- Discuss how compensation negotiation and budgeting impacts enrollment milestones
- Outline how stakeholders can work with their IRB partner to determine optimal compensation and build processes into their clinical trial design
Tuesday, May 18, 2021